GrowBLOX Sciences, Inc. Secures Special Use Permit for its Cultivation and Conversion Facility - Beckley, Bluefield & Lewisburg News, Weather, Sports

GrowBLOX Sciences, Inc. Secures Special Use Permit for its Cultivation and Conversion Facility

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact

SOURCE GrowBLOX Sciences, Inc.

LAS VEGAS, June 17, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (OTCQB: GBLX) a biotechnology and research company, today announced through its local partnership, GBS NEVADA, LLC, that it has secured a special use permit in Clark County, Nevada for its cultivation and conversion facility.  The Company completed its presentation to the Board of Commissioners and was successful in acquiring this special use permit for its proposed Las Vegas facility.  The Company will await final State approval and will be applying for a State business license in the coming weeks.

Clark County will hold three days of lengthy public hearings in order for applicants to present to the commission.  GBS NEVADA, LLC appeared before the Commission today, as Commissioners allowed the public time and access for rebuttals in their respective neighborhoods, and voted subsequent to the presentation.  Results were announced immediately thereafter.  A list of required information was set in ordinance and applicants were required to meet each and all ordinances.  The Company met all ordinances and will move forward in applying to the State for a business license to operate its cultivation and conversion facility.

GrowBLOX Sciences, CEO, Craig Ellins said, "More great news!  We are building on the momentum of securing a special use permit for our dispensary and now our cultivation and conversion facility.  This permit is instrumental in our vision of providing a superior medical-grade product to patients in need, as it will provide a necessary growth outlet to the community.  Clark County set the bar high and we have met and exceeded those parameters.  We are very delighted with the results."

The partnership was one of 70 applicants for cultivation facilities in Clark County and was granted a special use permit for it's medical marijuana establishment on Tuesday.  The Company's proposed 30,000 square feet West Teco Avenue location is ideal for The Company's cultivation, conversion and packaging facility, as it will provide the local community with jobs. 

About GrowBLOX Sciences, Inc.

GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation.  The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product.  The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are inherently unreliable and actual results may differ materially.  Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results.  Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission.  The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Jonathan Barkman
Riverview Capital Enterprises

©2012 PR Newswire. All Rights Reserved.